Harmony Biosciences (HRMY) director granted 21,231 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Harmony Biosciences Holdings, Inc. director Germano Geno J received a grant of stock options as equity compensation. The award covers 21,231 options for common stock at an exercise price of $30.76 per share and expires on May 14, 2036. These options vest in 36 equal monthly installments beginning on June 14, 2026. Following this grant, he holds 21,231 stock options directly, with no open-market share purchases or sales reported in this filing.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Germano Geno J
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 21,231 | $0.00 | -- |
Holdings After Transaction:
Stock Option — 21,231 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 21,231 options
Exercise price: $30.76 per share
Expiration date: May 14, 2036
+2 more
5 metrics
Options granted
21,231 options
Stock option grant to director Germano Geno J
Exercise price
$30.76 per share
Strike price for Harmony Biosciences common stock
Expiration date
May 14, 2036
Option term end date
Vesting schedule
36 monthly installments
Vesting begins June 14, 2026
Options held after grant
21,231 options
Total derivative holdings following this transaction
Key Terms
Stock Option, Grant, award, or other acquisition, vesting, Common Stock
4 terms
Stock Option financial
"security_title: "Stock Option" related to Harmony Biosciences common stock"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
vesting financial
"The stock option shall vest in 36 equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Common Stock financial
"underlying_security_title: "Common Stock" as the underlying security"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What insider transaction did Harmony Biosciences (HRMY) report for Germano Geno J?
Harmony Biosciences reported that director Germano Geno J received a grant of 21,231 stock options. These options relate to the company’s common stock and are part of his equity-based compensation, rather than an open-market purchase or sale of existing shares.
How many stock options were granted to Harmony Biosciences (HRMY) director Germano Geno J?
Germano Geno J was granted 21,231 stock options. The options give him the right to acquire Harmony Biosciences common stock at a fixed exercise price, subject to vesting over time as described in the award terms.
What is the exercise price of the new stock options at Harmony Biosciences (HRMY)?
The stock options granted to Germano Geno J have an exercise price of $30.76 per share. This means he can buy Harmony Biosciences common stock at $30.76 once the options vest, regardless of the market price at that time.
When do Germano Geno J’s Harmony Biosciences (HRMY) stock options vest?
The stock options begin vesting on June 14, 2026, in 36 equal monthly installments. This monthly vesting schedule spreads the award over three years, aligning the director’s incentives with the company’s longer-term performance and service period.
When do the newly granted Harmony Biosciences (HRMY) stock options expire?
The granted stock options expire on May 14, 2036. If Germano Geno J does not exercise the options by that expiration date, they will lapse and no longer provide the right to purchase Harmony Biosciences common shares at the set price.